Cargando…
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
Survival of gastrointestinal cancer remains dismal, especially for metastasized disease. For various cancers, especially melanoma and lung cancer, immunotherapy has been proven to confer survival benefits, but results for gastrointestinal cancer have been disappointing. Hence, there is substantial i...
Autores principales: | Bouzid, Rachid, Peppelenbosch, Maikel, Buschow, Sonja I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281593/ https://www.ncbi.nlm.nih.gov/pubmed/32365838 http://dx.doi.org/10.3390/cancers12051121 |
Ejemplares similares
-
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
por: Magré, Luc, et al.
Publicado: (2023) -
Empirical Evaluation of the Use of Computational HLA Binding as an Early Filter to the Mass Spectrometry-Based Epitope Discovery Workflow
por: Bouzid, Rachid, et al.
Publicado: (2021) -
CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
por: Buschow, Sonja I., et al.
Publicado: (2021) -
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
por: Ge, Zhouhong, et al.
Publicado: (2021) -
Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
por: Levink, Iris J. M., et al.
Publicado: (2022)